Non-profit pharma company Civica, established by hospitals, makes quality generic medications and biosimilar insulin available and affordable for all. Learn about Civica, CivicaScript, Civica Foundation, governance, leadership, membership and history.

Information on Civica manufacturing (Petersburg), medications hospitals use for emergency, surgery, ICU care and serious illness, CivicaScript medicines at the pharmacy counter, and affordable insulin biosimilars for consumers.

2022年3月3日 · Civica Rx announces plans to manufacture and distribute insulins that, once approved, will be available to people with diabetes at significantly lower prices than insulins currently on the market.

Civica job opportunities and career-building tools in professional and skilled manufacturing roles in Virginia, Utah and remote.

Dan Liljenquist is the lead architect and Board Chair of nonprofit generic drug company Civica Rx. Civica was established to reduce chronic generic drug shortages and price gouging, which have negatively impacted patient care for over a decade.

Hospital Sisters Health System Integris Health Intermountain Health Kaiser Permanente Kootenai Health Laura and John Arnold Foundation Mayo Clinic

Since 2018, despite shortages, Civica has been able to reliably supply our hospital members with the quality generic injectable medications that their patients need. Our model comprises: Essential medications in shortage or at risk of shortage identified …

2020年5月19日 · Civica Rx is part of a new U.S. Government-funded partnership that was announced today to produce essential generic medicines and their ingredients at one location in the United States.

“Civica Rx has already partnered with nearly 60 health systems, over 1,500 hospitals, and produced more than 60 drugs. This facility, set in Virginia, will help produce insulin and lower the cost from $300 to $30 per vial.

2021年6月15日 · Civica Rx announced today that CivicaScript is the name for its operating unit dedicated to lowering the cost of select high-cost generic medicines, and that one of the nation’s largest health insurers and a leading drug manufacturer are joining the initiative.